Functional Promoter -308G>A Variant in Tumor Necrosis Factor α Gene Is Associated with Risk and Progression of Gastric Cancer in a Chinese Population

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Hong, Yan ^a   Ge, Zhijun ^a   Jing, Changrui ^b   Shi, Jun ^a   Dong, Xiao ^c   Zhou, Fengying ^d   Wang, Meilin ^e   Zhang, Zhengdong ^e   Gong, Weida ^a,c,e  

^a YIXING PEOPLE S HOSPITAL   (China)

^b WUXI NO 2 PEOPLE S HOSPITAL   (China)

^c Yixing Cancer Hospital   (China)

^d The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CHINESE; CLINICAL EVALUATION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; TUMOR GENE; TUMOR NECROSIS FACTOR ALPHA GENE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872236172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050856     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Hohenberger P, Gretschel S, (2003) Gastric cancer. Lancet 362: 305-315.
3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789.
4. Crew KD, Neugut AI, (2004) Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31: 450-464.
5. Yoshida T, Ono H, Kuchiba A, Saeki N, Sakamoto H, (2010) Genome-wide germline analyses on cancer susceptibility and GeMDBJ database: Gastric cancer as an example. Cancer Sci 101: 1582-1589.
6. Wang M, Zhang R, He J, Qiu L, Li J, et al. (2012) Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One 7: e31932.
7. Shi Y, Hu Z, Wu C, Dai J, Li H, et al. (2011) A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet 43: 1215-1218.
8. You WC, Zhang L, Gail MH, Chang YS, Liu WD, et al. (2000) Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 92: 1607-1612.
9. Peek RM Jr, Blaser MJ, (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37.
10. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, et al. (2001) Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 54: 703-706.
11. Thalmaier U, Lehn N, Pfeffer K, Stolte M, Vieth M, et al. (2002) Role of tumor necrosis factor alpha in Helicobacter pylori gastritis in tumor necrosis factor receptor 1-deficient mice. Infect Immun 70: 3149-3155.
12. Senthilkumar C, Niranjali S, Jayanthi V, Ramesh T, Devaraj H, (2011) Molecular and histological evaluation of tumor necrosis factor-alpha expression in Helicobacter pylori-mediated gastric carcinogenesis. J Cancer Res Clin Oncol 137: 577-583.
13. Raabe T, Bukrinsky M, Currie RA, (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273: 974-980.
14. Kroeger KM, Carville KS, Abraham LJ, (1997) The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34: 391-399.
15. Li C, Xia B, Yang Y, Li J, Xia HH, (2005) TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 100: 290-294.
16. Lu W, Pan K, Zhang L, Lin D, Miao X, et al. (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 26: 631-636.
17. Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, et al. (2002) Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 185: 106-109.
18. Fei BY, Xia B, Deng CS, Xia XQ, Xie M, et al. (2004) Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population. World J Gastroenterol 10: 1256-1261.
19. Guo W, Wang N, Li Y, Zhang JH, (2005) Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med J (Engl) 118: 1870-1878.
20. Zhang J, Dou C, Song Y, Ji C, Gu S, et al. (2008) Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis. J Hum Genet 53: 479-489.
21. Gorouhi F, Islami F, Bahrami H, Kamangar F, (2008) Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer 98: 1443-1451.
22. Zhou F, Zhu H, Luo D, Wang M, Dong X, et al. (2012) A Functional Polymorphism in Pre-miR-146a Is Associated with Susceptibility to Gastric Cancer in a Chinese Population. DNA Cell Biol.
23. Grimm M, Lazariotou M, Kircher S, Hofelmayr A, Germer CT, et al. (2010) Tumor necrosis factor-alpha is associated with positive lymph node status in patients with recurrence of colorectal cancer- indications for anti-TNF-alpha agents in cancer treatment. Anal Cell Pathol (Amst) 33: 151-163.
24. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, et al. (1993) Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53: 1982-1985.
25. Fujiki H, Suganuma M, (2011) Tumor promoters-microcystin-LR, nodularin and TNF-alpha and human cancer development. Anticancer Agents Med Chem 11: 4-18.
26. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, et al. (1999) The immune system in the elderly: II. Specific cellular immunity. Immunol Res 20: 109-115.
27. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, et al. (2002) T cells and aging, January 2002 update. Front Biosci 7: d1056-1183.
28. Balkwill F, (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13: 135-141.
29. Fujiki H, Suganuma M, Komori A, Yatsunami J, Okabe S, et al. (1994) A new tumor promotion pathway and its inhibitors. Cancer Detect Prev 18: 1-7.
30. Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP, et al. (2011) Association of-308 TNF-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol 47: 888-894.
31. Harris PR, Mobley HL, Perez-Perez GI, Blaser MJ, Smith PD, (1996) Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 111: 419-425.